DanCann Pharma A/S aims to accelerate business and revenue growth: Comprehensive strategy update to follow in October
COPENHAGEN, Denmark, 02 October 2023 – DanCann Pharma A/S, DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, is embarking on a strategic initiative designed to drive accelerated revenue growth in the coming year. This move comes as the Company prepares to introduce a range of new products to the market in 2024.DanCann Pharma is presently in the process of formulating a new strategic roadmap aimed at propelling the Company toward success. This strategic reevaluation underscores the Company's commitment to addressing